Quick Answer
C4 Therapeutics, Inc. reported Total Assets of $359.07 million for fiscal year 2025.
C4 Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $359.07M | +2.7% |
| 2024 | $349.60M | -7.1% |
| 2023 | $376.45M | -12.6% |
| 2022 | $430.84M | -15.0% |
| 2021 | $506.76M | +26.6% |
| 2020 | $400.14M | +238.4% |
| 2019 | $118.26M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $265.49M | -29.4% | -10.5% |
| June 30, 2025 | $296.53M | -22.2% | -7.2% |
| March 31, 2025 | $319.52M | -19.8% | -8.6% |
| December 31, 2024 | $349.60M | -7.1% | -7.0% |
| September 30, 2024 | $376.06M | +12.9% | -1.3% |
| June 30, 2024 | $381.09M | +1.6% | -4.3% |
| March 31, 2024 | $398.37M | +0.6% | +5.8% |
| December 31, 2023 | $376.45M | -12.6% | +13.0% |
- C4 Therapeutics, Inc. showed an increase of +2.7% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, C4 Therapeutics, Inc.’s total assets has grown by 203.6% (from $118.26 million to $359.07 million).
- The most recent figure is from C4 Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: